机构:[1]Southwest Med Univ, Sch Pharm, Luzhou, Peoples R China[2]Sichuan Acad Chinese Med Sci, Sichuan Inst Translat Chinese Med, Sichuan Engn Technol Res Ctr Genuine Reg Drug, Sichuan Prov Engn Res Ctr Format Principle & Qual, Chengdu, Peoples R China[3]Univ Elect Sci & Technol China, Radiat Oncol Key Lab Sichuan Prov, Sichuan Canc Ctr, Dept Radiat Oncol,Sichuan Clin Res Ctr Canc,Affili, Chengdu, Peoples R China四川省肿瘤医院[4]Chengdu Univ, Coll Food & Biol Engn, Chengdu, Peoples R China[5]Southwest Med Univ, Tradit Chinese Med Hosp, Class Chinese Med Diag & Treatment Ctr, Luzhou, Peoples R China
The gut microbiota is not just a simple nutritional symbiosis that parasitizes the host; it is a complex and dynamic ecosystem that coevolves actively with the host and is involved in a variety of biological activities such as circadian rhythm regulation, energy metabolism, and immune response. The development of the immune system and immunological functions are significantly influenced by the interaction between the host and the microbiota. The interactions between gut microbiota and cancer are of a complex nature. The critical role that the gut microbiota plays in tumor occurrence, progression, and treatment is not clear despite the already done research. The development of precision medicine and cancer immunotherapy further emphasizes the importance and significance of the question of how the microbiota takes part in cancer development, progression, and treatment. This review summarizes recent literature on the relationship between the gut microbiome and cancer immunology. The findings suggest the existence of a "symbiotic microecosystem" formed by gut microbiota, metabolome, and host immunome that is fundamental for the pathogenesis analysis and the development of therapeutic strategies for cancer.
基金:
Oncology Medical-Industrial Innovation Fund Project of University of Electronic Science and Technology, Sichuan Cancer Hospital [ZYGX2021YGCX020]; Sichuan Cancer Hospital Youth Fund Project [YB2021035, YB2021040]; National Natural Science Foundation of China [82204695, 82104215]; Sichuan Provincial Research Institutes Basic Research Operations Fund Project [A-2022N-Z-2]; Sichuan Administration of TCM [2021ZD004]; Sichuan Academy of Traditional Chinese Medicine Research Project [QNCJRSC2022-9]
第一作者机构:[1]Southwest Med Univ, Sch Pharm, Luzhou, Peoples R China[2]Sichuan Acad Chinese Med Sci, Sichuan Inst Translat Chinese Med, Sichuan Engn Technol Res Ctr Genuine Reg Drug, Sichuan Prov Engn Res Ctr Format Principle & Qual, Chengdu, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Southwest Med Univ, Sch Pharm, Luzhou, Peoples R China[2]Sichuan Acad Chinese Med Sci, Sichuan Inst Translat Chinese Med, Sichuan Engn Technol Res Ctr Genuine Reg Drug, Sichuan Prov Engn Res Ctr Format Principle & Qual, Chengdu, Peoples R China
推荐引用方式(GB/T 7714):
Xue Xiaoyu,Li Rui,Chen Zhenni,et al.The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome[J].FRONTIERS IN IMMUNOLOGY.2023,14:doi:10.3389/fimmu.2023.1235827.
APA:
Xue, Xiaoyu,Li, Rui,Chen, Zhenni,Li, Guiyu,Liu, Bisheng...&Tan, Ruirong.(2023).The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome.FRONTIERS IN IMMUNOLOGY,14,
MLA:
Xue, Xiaoyu,et al."The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome".FRONTIERS IN IMMUNOLOGY 14.(2023)